CMS to Approve Coverage of NGS-based Cancer Testing | Big Pharma’s Response & The effect on PM
Why this is a Big Deal? As we know, private insurers follow suit once Medicare makes a decision such as this. This portends well for genetic testing to become routine standard of care for patients with advanced cancers. ...